On November 20th I hosted a panel of experts representing medical devices, diagnostics, research tools, and biopharma at Minnesota’s LifeScience Alley’s 2013 annual conference. The… Read more
Nsight Barbara Nelsen on the business of science.
We’re well into the era when dwindling venture capital is no longer the first or best option for raising money to seed a new company… Read more
Successful fundraising campaigns target investors whose interests match the firm’s product offerings and stage of development. If you have an early-stage life science company looking… Read more